Hidradenitis suppurativa
ICD-10 L73.2 is a billable code used to indicate a diagnosis of hidradenitis suppurativa.
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by recurrent painful nodules, abscesses, and sinus tracts primarily affecting areas with apocrine glands, such as the axillae, groin, and under the breasts. The condition often begins after puberty and is more prevalent in women than men. HS can lead to significant physical discomfort and psychological distress due to its chronic nature and visibility. The disease progresses through stages, starting with painful lumps that can rupture and drain pus, leading to scarring and skin changes over time. Diagnostic considerations include a thorough clinical history and physical examination, as well as ruling out other conditions such as folliculitis or skin infections. Imaging studies may be utilized in severe cases to assess the extent of the disease. Early diagnosis and management are crucial to prevent complications and improve quality of life for affected individuals.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L73.2 specifically covers hidradenitis suppurativa, which may present with recurrent abscesses, nodules, and scarring in areas with apocrine glands. It is important to differentiate HS from other skin conditions such as acne or folliculitis.
L73.2 should be used when the patient presents with classic symptoms of hidradenitis suppurativa, particularly when there is a history of recurrent lesions and significant scarring. It is essential to document the chronicity and severity to justify the use of this specific code.
Documentation should include a detailed history of the patient's symptoms, physical examination findings, treatment history, and any imaging studies if performed. Notes should clearly indicate the recurrent nature of the lesions and any associated complications.
